SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (344)4/21/1999 1:32:00 PM
From: aknahow  Read Replies (1) of 3158
 
Rich, I am less optimistic that merging one cash hungry start up with another is feasible. Any merger creates a diversion of efforts and is not without cost. If they were the solution, we would have seen them occur by now. The problem of financing is a real problem and not easy to resolve.

Biotechs seem to think that even with problems on the financing front they can afford to delay release of trial results for months while awaiting what they consider an appropriate forum. This might seem like a minor issue but it is one of the straws that make biotech investing more of a hazard. Non disclosure of royalties paid or earned is another. With all the cost and risk of drug development why add to the unknowns?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News